Literature DB >> 6176316

Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases.

E Robin, J D Bitran, H M Golomb, S Newman, P C Hoffman, R K Desser, T R DeMeester.   

Abstract

Prognostic factors were examined in 38 patients with nonsmall cell lung carcinoma and brain metastases. The most important factors were the response to total therapy (corticosteroids, radiotherapy, and chemotherapy) and the presence of brain metastases alone; these factors had the most impact on survival. Age, sex, histologic type of lung cancer, and initial performance status were not prognostically important. Our results indicate that certain subgroups of patients with nonsmall cell lung carcinoma and brain metastases have a favorable prognosis and should be treated aggressively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176316     DOI: 10.1002/1097-0142(19820501)49:9<1916::aid-cncr2820490926>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience.

Authors:  O F Lange; W Scheef; K D Haase
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer.

Authors:  T Umsawasdi; M Valdivieso; T T Chen; H T Barkley; D J Booser; D F Chiuten; H M Dhingra; W K Murphy; C L Dixon; P Farha
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 3.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.

Authors:  H Nakagawa; Y Miyawaki; T Fujita; S Kubo; K Tokiyoshi; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.